Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( November )
What's your career plan?
A successful career is not just about luck - planning ahead can help create the opportunities which will ultimately lead to job satisfaction, says Paul-Stuart Kregor(more)
Managed Entry: creating a dialogue ahead of your launch
Communicating with NHS decision-makers on a strategic level before launch can be beneficial for all sides and help foster collaboration and understanding, says Mike Weetman(more)
Good Publication Practice 2: updating best practice
You could help shape new guidelines for clinical trials publications, says Chris Graf(more)
PharmafocusNews Register for New Alert
News for September 2008
Previous Months: October 2008 |  September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Latest news from Datamonitor
Is cost containment impacting pharmaceutical innovation?..(more)

 Merck's Kuvan set for European approval
Orphan drug on track to be first treatment for two neurological disorders..(more)

 Lilly to reveal doctor payments
Company will disclose details of US relationships..(more)

 Pradaxa approved by NICE
Boehringer Ingelheim gains marketing edge over Bayer's rival drug..(more)

 Gardasil and Cervarix share innovation prize
Rival vaccines declared joint winners of UK Prix Galien..(more)

 Brown to scrap prescription costs for cancer patients
Charges will be scrapped from April next year..(more)

 Latest news from Datamonitor
Monoclonal antibody sales to almost double by 2013..(more)

 Sanofi seals Zentiva deal with improved offer
Czech generics company drops opposition to takeover bid..(more)

 Once-daily Seroquel launched
AstraZeneca unveils new version of schizophrenia drug in UK..(more)

 Ban on 'top-up' payments for drugs not working
King's Fund says current situation is untenable..(more)

 Giuliani to argue Ranbaxy's case in US
Indian generics firm seeking to reverse FDA import block..(more)

 GSK unveils new cancer unit
Integrated R&D unit will be led by Paolo Paoletti..(more)

 PCTs told to explain how drug funding decisions are reached
Department of Health requests information from Trusts' chief executives..(more)

 GSK seeks risk-sharing deal for Tyverb
Company has approached UK government with new pricing arrangement..(more)

 Amgen sells off two biotech products
Niche products snapped up by Biovitrum..(more)

 Latest news from Datamonitor
UK watchdog's guidance knocks kidney cancer drugs..(more)

 Sanofi look for stronger leadership in GSK's Viehbacher
Company loses confidence in Gerald Le Fur..(more)

 Lilly launches diabetes patient education programme
Initiative comes to Europe ahead of Latin America and Asia..(more)

 Patient wins legal battle for Revlimid
High Court rules PCT decision to deny the drug was unreasonable..(more)

 Postcode lottery of care persists in England
King's Fund highlights variation in PCT spending..(more)

 Merck Serono takes lead role in antibody partnership
Assumes responsibility for funding atacicept's development and gains full marketing rights..(more)

 Government looks set to allow top-up fees
New NICE guidance for 'non-NHS' drugs key part of plans..(more)

 Viehbacher leaves GSK for Sanofi
Move to a top position at the French company just months away..(more)

 Oxford BioMedica unsettled by chief executive's departure
Dr Mike McDonald steps down after just one month with the company..(more)

 European research centres unite to battle cancer
New group brings together institutes in Holland, France and Sweden..(more)

 Latest news from Datamonitor
Drug lifecycle management could be the answer to the $100 billion question..(more)

 Experts play down Inergy cancer risk
Patients advised not to stop taking cholesterol-lowering drug..(more)

 Pfizer to co-market new Alzheimer's drug
Partners with San Francisco company Medivation..(more)

 Setback for Pfizer and BMS clotting drug
Apixaban fails to meet phase III trial endpoint..(more)

 Danish court overturns Lipitor patent challenge
Ranbaxy may now have to pay damages to Pfizer..(more)

 Latest news from Datamonitor
Attention shifts from beta-amyloid to tau in the hunt for an Alzheimer's disease therapy..(more)

 New Lucentis pricing to increase NHS prescriptions
NICE reverses decision on macular degeneration drug..(more)

 Scottish schools first to deliver new cancer jab
National immunisation programme begins this week..(more)

 North West to pilot first regional allergy centre
SHA will develop model centre for the rest of the country..(more)

 Latest news from Datamonitor
Pfizer R&D changes expected to increase number of late stage products..(more)

 Roche named and shamed for Code breaches
Adverts appeared in the BMJ and The Pharmaceutical Journal..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.